Eccladex 100 ug/ml Concentrated solution for intravenous infusion.
PDF Leaflet Revision Date: 11 April 2025
Clinical Summary
Quick overview from the medicine insert
Indication
ICU sedation and monitored anaesthesia care.
Dosage (summary)
Loading: 1 mcg/kg over 10 mins; Maintenance: 0.2-0.7 mcg/kg/hr.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy or lactation.
Key Drug Interactions
- Anaesthetics
- Sedatives
- Opioids
Contraindications
- Hypersensitivity
- Sepsis
- Unstable trauma
- Hypovolaemia
- Heart block
- Uncontrolled cardiac failure
- Imminent hepatic failure
- Uncontrolled hypotension
Common side effects
- Hypotension
- Bradycardia
- Respiratory depression
Counselling Points
- Avoid driving for 24 hours post-surgery
- Monitor for signs of hypotension or bradycardia
- Not suitable for deep sedation
Serious warnings
- Continuous monitoring required
- Risk of bradycardia and sinus arrest
Important Disclaimer
The Eccladex 100 ug/ml Concentrated solution for intravenous infusion. professional information leaflet below is the property of Equity Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
